 pharmacolog antiandrogen valu androgen suppress antiandrogen therapi antiandrogen abl effect androgen target cell bind androgen receptor AR chemic class antiandrogen market clinic trial steroid cyproteron acet nonsteroid flutamid steroid antiandrogen interact AR progestin glucocorticoid receptor rise glucocorticoid effect contrast nonsteroid antiandrogen AR devoid hormon antihormon activ nilutamid activ metabolit flutamid interact dog rat human prostat AR vitro kinet prolong interact AR vivo administr prostat cancer treatment necessari antiandrogen surgic chemic lh-rh agonist castrat complet suppress androgen antiandrogen target site trophic effect adren androgen intact castrat secret treatment adrenalectomi ketoconazol corticoid synthesi nilutamid trophic effect prostat castrat rat adren androgen minipump level similar castrat men nilutamid flare-up effect testosteron increas lh-rh agonist begin treatment rat buserelin increas prostat weight initi day treatment lh-rh agonist combin treatment nilutamid combin treatment nilutamid castrat experiment androgen-depend cancer model shionogi tumor administr nilutamid twenty-four hour inocul tumor cell appear tumor number absenc androgen effect antiandrogen activ product human tumor cell cultur cell mmtv androgen-depend promot cat report gene